UPC: שווי שוק לרווח Universe Pharma

Universe Pharmaceuticals generates revenue from the sale of herbal remedies for the elderly in China. The company is modernizing its plants and expanding its retail network in the southern part of the country. The current P/E ratio on the GURU.Markets platform is -0.50. The stock's price history demonstrates the sector's resilience to crises, although geopolitical tensions and sanction risks within raw material supply chains may exert pressure on quotes.

The P/E ratio history of Universe Pharmaceuticals (UPC) reflects the market valuation of the business within the traditional medicine sector. This ratio compares current market capitalization to net income, revealing the extent to which the asset is overvalued or undervalued. The indicator's trend is sensitive to earnings fluctuations, which are stabilized by diversification between the pharmacy chain and tonic agents. This mitigates the risks of government price regulation. Analyzing the curve allows for the identification of optimal entry points.